The project will contribute new insights into the molecular regulation of FGF23 in health and in CKD, and support our ultimate goal of developing novel therapeutic approaches to improve outcomes in CKD.
|Effective start/end date||8/1/15 → 9/15/20|
- National Institute of Diabetes and Digestive and Kidney Diseases (5R01DK102815-05)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.